Initially, our investigation delved into the mutational landscape of OPA1 and OPA3 genes within breast cancer (BRCA), meticulously scrutinizing their interplay with other established cancer-related genes such as PIK3CA, TP53, CDH1, PTEN, BRCA1/2, among others (Fig. 1B&E). This evidence concerns the gene CDH1 and breast carcinoma.